What Changed
Price Move History
- Daily moves over 5%
- 0 191 sessions, October 8, 2025 to October 20, 2026
- Largest daily move
- +0.8% close of June 16, 2026
- 1-year change
- +4.1% closing prices, October 8, 2025 to October 20, 2026
- 1-month change
- +0.5% closing prices, September 18, 2026 to October 20, 2026
Company Description
Jackson Acquisition Company II is a special purpose acquisition company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is a blank-check issuer rather than an operating company with commercial products or operating revenue from a conventional business line. Its public-company identity is centered on its SPAC structure, its listed securities, its capital structure and its search for an initial business combination.
The company may pursue a business combination in any industry or geographic location. Its stated search focus is on businesses in healthcare services, healthcare technology or other areas of the healthcare industry. That focus defines the target categories described by the company, while the SPAC structure gives it flexibility to evaluate a range of potential transactions within or outside those categories.
Jackson Acquisition Company II is organized as a Cayman Islands registrant and is associated with ordinary shares traded under the symbol JACS on the New York Stock Exchange. The company has also identified itself as an emerging growth company in its regulatory filings. Its disclosure profile is typical of a blank-check issuer: public records center on formation, securities, governance, shareholder matters, exchange-listing compliance and the mechanics that apply before a business combination is completed.
SPAC structure and corporate status
As a SPAC, Jackson Acquisition Company II was created to combine with an existing business rather than to build an operating platform organically. Until an initial business combination is completed, its durable corporate profile is defined by its acquisition purpose, public listing, governing documents, shareholder base and compliance with exchange and securities-law requirements.
The company has disclosed a New York Stock Exchange continued-listing matter involving the minimum public stockholder requirement under Section 802.01B of the NYSE Listed Company Manual. The company stated that the notice had no immediate impact on its securities and described the plan process available under NYSE procedures. This type of disclosure is part of the company’s public-company status record and does not change its stated role as a blank-check company formed to pursue a business combination.
Stock Performance
Jackson Acquisition Company II (JACS) closed at $10.83 on October 20, 2026. Over the past 12 months, the price has gained 4.1%.
JACS Metrics & Rankings
Price returns through October 20, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Jackson Acquisition Company II has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all JACS news →
SEC Filings
Jackson Acquisition Company II has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G/A, 2 Form 10-Q, 2 Form SCHEDULE 13G, 1 Form PRE 14A. The most recent filing was submitted on October 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all JACS SEC filings →
Financial Highlights
operating income reached -$569K, and net income was $9.1M. The company generated -$428K in operating cash flow. The current ratio was 1.54, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Jackson Acquisition Company II (JACS) currently stands at 2.1 thousand shares, up 51.0% from the previous reporting period, representing 0.0% of the float. Since October 2025, short interest has decreased by 37.7%.
Days to Cover History
Days to cover for Jackson Acquisition Company II (JACS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 13.8 days.
JACS Company Profile & Sector Positioning
Jackson Acquisition Company II (JACS) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NYSE.
Investors comparing JACS often look at related companies in the same sector, including Drugs Made In America Acquisition Corp. Units (DMAAU), Andretti Acquisition Corp. II (POLE), Graf Global Corp. (GRAF), Archimedes Tech SPAC Partners II Co. (ATII), and Voyager Acquisition Corp (VACH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate JACS's relative position within its industry.